Aperio Group, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,049,000
+54.1%
38,326
+18.9%
0.01%
+50.0%
Q3 2020$1,330,000
-17.1%
32,226
-2.6%
0.00%
-33.3%
Q2 2020$1,604,000
+27.3%
33,083
+10.9%
0.01%0.0%
Q1 2020$1,260,000
+5.4%
29,821
+6.7%
0.01%
+50.0%
Q4 2019$1,196,000
+35.3%
27,953
+13.8%
0.00%
+33.3%
Q3 2019$884,000
+54.5%
24,568
+14.9%
0.00%
+50.0%
Q2 2019$572,000
+23.5%
21,384
+23.9%
0.00%0.0%
Q1 2019$463,000
+80.2%
17,257
+8.4%
0.00%
+100.0%
Q4 2018$257,000
-20.9%
15,918
+1.5%
0.00%0.0%
Q3 2018$325,000
+28.5%
15,679
-5.5%
0.00%0.0%
Q2 2018$253,000
-35.9%
16,586
-5.7%
0.00%
-50.0%
Q1 2018$395,000
-28.1%
17,593
-3.5%
0.00%
-33.3%
Q4 2017$549,000
-19.1%
18,226
+1.1%
0.00%
-25.0%
Q3 2017$679,000
+37.2%
18,031
+1.6%
0.00%
+33.3%
Q2 2017$495,000
-31.2%
17,752
-15.3%
0.00%
-40.0%
Q1 2017$720,000
+20.6%
20,951
+1.3%
0.01%0.0%
Q4 2016$597,000
+1.2%
20,688
+11.5%
0.01%
+25.0%
Q3 2016$590,000
+2.1%
18,557
+4.3%
0.00%
-20.0%
Q2 2016$578,000
+9.1%
17,797
-6.2%
0.01%0.0%
Q1 2016$530,000
+1.5%
18,964
+29.6%
0.01%0.0%
Q4 2015$522,000
+14.0%
14,629
+5.5%
0.01%0.0%
Q3 2015$458,000
-22.8%
13,860
-2.1%
0.01%
-16.7%
Q2 2015$593,000
+105.2%
14,156
+59.7%
0.01%
+100.0%
Q1 2015$289,000
+3.6%
8,866
+1.1%
0.00%0.0%
Q4 2014$279,000
+36.1%
8,773
+4.2%
0.00%0.0%
Q1 2014$205,000
-6.4%
8,421
+5.4%
0.00%
-25.0%
Q3 2013$219,0007,9860.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders